News

Find News

Filter articles

Applied Filters

Showing 21 to 30 of 832 results

Sandoz secures victory against GSK in passing off case

UK08-10-2019Sarah Morgan

The English High Court has sided with pharmaceutical company Vectura and Novartis-owned Sandoz in a passing off lawsuit brought by rival GSK.

Fed Circuit overturns Apotex’s PTAB victory

US07-10-2019Sarah Morgan

The US Court of Appeals for the Federal Circuit last week reversed a Patent Trial and Appeal Board decision, which found that claims in an OSI Pharmaceuticals patent for cancer treatment were obvious.

Bausch targets Sandoz over IBS generic

US03-10-2019Rory O'Neill

Canadian pharmaceutical company Bausch Health is suing Sandoz for patent infringement over its notice of intent to release a generic version of Xifaxan, Bausch’s irritable bowel syndrome drug.

FDA and DEA warn over sale of misbranded opioid drugs

01-10-2019Saman Javed

The US Food and Drug Administration and Drug Enforcement Administration have issued joint warning letters to four online networks which allegedly sell unapproved and misbranded versions of medicines.

UK parliament report reveals threat to medical supplies post-Brexit

UK27-09-2019Rory O'Neill

An independent parliamentary report has today, September 27, revealed that the UK’s health ministry remains unsure whether the country’s health service can fully withstand the impact of a no-deal Brexit next month.

China awards generics contracts to lowest bidders

China26-09-2019Rory O'Neill

China’s drug pricing overhaul has seen the average cost of drugs drop by more than half, the country’s Joint Procurement Office announced this week.

UK Labour promises public generics company, compulsory drug licensing

UK25-09-2019Rory O'Neill

Jeremy Corbyn, leader of the UK Labour Party, has pledged to create a publicly-owned drugs manufacturer and use compulsory licensing to sell generic, lower priced versions of drugs to the country’s National Health Service.

US Senators urge FTC to closely scrutinise pharma mergers

US19-09-2019Saman Javed

A group of senators has urged the US Federal Trade Commission to closely scrutinise mergers in the pharmaceutical industry, which it said “increase competition issues and stifle innovation”.

Duke and Allergan escape antitrust claims in Akorn suit

US19-09-2019Sarah Morgan

A US judge dismissed antitrust counterclaims brought against Allergan and Duke University earlier this week, in a lawsuit the pair filed against generics maker Akorn.

AIPPI World Congress 2019: SPC and PTEs around the world

EU, Japan, US17-09-2019Saman Javed

This week at the AIPPI World Congress 2019, counsel discussed how supplementary protection certificates and patent term extension regulations differ across jurisdictions.

Showing 21 to 30 of 832 results

LSIPR